BoneR.C.Let's agree on terminology: definitions of sepsis. Crit Care Med1991;19(7):973–976.
2.
LowryS.F.Sepsis and its complications: clinical definitions and therapeutic prospects. Crit Care Med1994;22(7):S1–S2.
3.
Increase in National Hospital Discharge Survey rates for septicemia-United States, 1979-1987. MMWR Morb Mortal Wkly Rep1990;39(2):31–34.
4.
Resuscitation of patients in septic shock. Consensus Conference. Intensive Care World1998;15:72–83.
5.
DannerR.L., ElinR.J., HosseiniJ.M., WesleyR.A., ReillyJ.M., ParilloJ.E.Endotoxemia in human septic shock. Chest1991;99(1):169–175.
6.
NatansonC., HoffmanW.D., SuffrediniA.F., EighackerP.Q., DannerP.L.Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis (review). Ann Intern Med1994;120(9):771–783.
7.
MarlettaM.A., YoonP.S., IyengarR., LeafC.D., WishnokJ.S.Macrophage oxidation of L-arginine to nitrite and nitrate: Nitric oxide is an intermediate. Biochemistry1988;27(24):8706–8711.
8.
StuehrD.J., GrossS.S., SakumaI., LeviR., NathanC.F.Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J Exp Med1989;169(3):1011–1020.
9.
StewartT.E., ValenzaF., RibeiroS.P., WenerD.A., VolgyesiG., NullenJ.B., SlutskyA.S.Increased NO in exhaled gas as an early marker of lung inflammation in a model of sepsis. Am J Respir Crit Care Med1995;151(3 Pt 1):713–718.
10.
EvansT., CarpenterA., KindermanH., CohenJ.Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock1993;41(2):77–81.
11.
WrightC.E., ReesD.D., MoncadaS.Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res1992;26(1):48–57.
CohenR.I., ShapirY., ChenL., ScharfS.M.Right ventricular overload causes the decrease in cardiac output after nitric oxide synthesis inhibition in endotoxemia. Crit Care Med1998;26(4):738–747.
14.
CobbJ.P., NatansonC., QuezadoZ.M.N., HoffmanW.D., KoevC.A., BanksS., et al. Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs. Am J Physiol1995;268(4 Pt 2):H1634–H1642.
15.
KilbournR.G., CromeensD.M., ChellyF.D., GriffithO.W.N-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs. Crit Care Med1994;22(11):1835–1840.
16.
MeyerJ., LentzC.W., StrothertJ.C.Jr, TraberL.D., HerndonD.N., TraberD.L.Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. Crit Care Med1994;22(2):306–312.
17.
HendersonJ.L., StatmanR., CunninghamJ.N., ChengW., DamianiP., SiconolfiA., HorovitzJ.H.The effects of nitric oxide inhibition on regional hemodynamics during hyperdynamic endotoxemia. Arch Surg1994;129(12):1271–1275.
18.
StatmanR., ChengW., CunninghamJ.N., HendersonJ.L., DamianiP., SiconolfiA., RogersD., HorovitzJ.H.Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation. J Surg Res1994;57(1):93–98.
19.
MitakaC., HirataY., IchikawaK., UchidaT., YokoyamaK., NaguraT., TsunodaY., AmahaK.Effects of nitric oxide synthase inhibitor on hemodynamic changes and O₂ delivery in septic dogs. Am J Physiol1995;268(5 Pt 2):H2017–H2023.
20.
CobbJ.P., NatansonC., HoffmanW.D., LodatoR.F., BanksS., KoevC.A., SolomonM.A., ElinR.J., HosseiniJ.M., DannerR.L.N"-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med1992;176(4):1175–1182.
21.
NavaE., PalmerR.M.J., MoncadaS.Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?Lancet1991;338(8782-8783):1555–1557.
22.
MorrisS.M.Jr, BilliarT.R.New insights into the regulation of inducible nitric oxide synthesis (review). Am J Physiol1994;266(6 Pt 1):E829–E839.
23.
LaszloF., WhittleB.J.R., EvansS.M., MoncadaS.Association of microvascular leakage with induction of nitric oxide synthase: effects of nitric oxide synthase inhibitors in various organs. Eur J Pharmacol1995;283(1-3):47–53.
24.
GardinerS.M., KempP.A., MarchJ.E., BennettT.Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Br J Pharmacol1995;116(3):2005–2016.
25.
AaronS.D., ValenzaF., VolgyesiG., MullenJ.B.M., SlutskyA.S., StewartT.E.Inhibition of exhaled nitric oxide production during sepsis does not prevent lung inflammation. Crit Care Med1998;26(2):309–314.
26.
ZhangH., RogiersP., PrieserJ-C., SpapenH., ManikisP., MetzG., VincentJ-L.Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock. Crit Care Med1995;23(10):1711–1721.
27.
KnowlesR.G., SalterM., BrooksS.L., MoncadaS.Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem Biophys Res Commun1990;172(3):1042–1048.
28.
PayaD., GrayG.A., FlemingI., StocletJ.C.Effect of dexamethasone on the onset and persistence of vascular hyporeactivity induced by E. coli lipopolysaccharide in rats. Circ Shock1993;41(2):103–112.
29.
AranowJ.S., ZhuangJ., WangH., LarkinV., SmithM., FinkM.P.A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: comparison with two nonselective strategies. Shock1996;5(2):116–121.
30.
VromenA., ArkovitzM.S., ZingarelliB., SalzmanA.L., GarciaV.F., SzaboC.Low-level expression and limited role for the inducible isoform of nitric oxide synthase in the vascular hyporeactivity and mortality associated with cecal ligation and puncture in the rat. Shock1996;6(4):248–253.
31.
PetrosA., BennettD., VallanceP.Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet1991;338(8782-8783):1557–1558.
32.
AvontuurJ.A., Tutein NoltheniusR.P., van BodegomJ.W., BruiningH.A.Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study. Crit Care Med1998;26(4):660–667.
33.
KiehlM.G., OstermannH., MeyerJ., KienastJ.Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock. Intensive Care Med1997;23(5):561–566.
34.
AvontuurJ.A., BiewengaM., BuijkS.L., KanhaiK.J., BruiningH.A.Pulmonary hypertension and reduced cardiac output during inhibition of nitric oxide synthesis in human septic shock. Shock1998;9(6):451–454.
35.
AvontuurJ.A., Tutein NoltheniusR.P., BuijkS.L., KanhaiK.J., BruiningH.A.Effect of L-NAME, an inhibitor of nitric oxide synthesis, on cardiopulmonary function in human septic shock. Chest1998;113(6):1640–1646.
36.
SchneiderF., LutunP., HasselmannM., StocletJ.C., TempeJ.D.Methylene blue increases systemic vascular resistance in human septic shock: preliminary observations. Intensive Care Med1992;18(5):309–311.
37.
PreiserJ-C., LejeuneP., RomanA., CarlierE., De BackerD., LeemanM., KahnR.J., VincentJ-L.Methylene blue administration in septic shock: a clinical trial. Crit Care Med1995;23(2):259–264.
38.
Daemen-GubbelsC.R., GroeneveldP.H., GroeneveldA.B., van KampG.J., BronsveldW., ThijsL.G.Methylene blue increases myocardial function in septic shock. Crit Care Med1995;23(8):1363–1370.
39.
ZhangH., RogiersP., SmailN., CabralA., VincentJ-L.Effects of nitric oxide on blood flow distribution and O₂ extraction capabilities during endotoxic shock. J Appl Physiol1997;83(4):1164–1173.
40.
PastorC.M., LosserM.R., PayenD.Nitric oxide donor prevents hepatic and systemic perfusion decrease induced by endotoxin in anesthetized rabbits. Hepatology1995;22(5):1547–1553.
41.
Boughton-SmithN.K., HutchesonI.R., DeakinA.M., WhittleB.J., MoncadaS.Protective effect of S-nitroso-N-acetyl-penicillamine in endotoxin-induced acute intestinal damage in the rat. Eur J Pharmacol1994;191(3):485–488.
42.
ChristopherT.A., MaX-L., LeferA.M.Beneficial actions of S-nitroso-N-acetylpenicillamine, a nitric oxide donor, in murine traumatic shock. Shock1994;1(1):19–24.
